Cargando…

Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial

BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jee Youn, Lee, Chang-Soon, Yoo, Yongjae, Lee, Suji, Lee, Sang Hoon, Lee, Seunghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748203/
https://www.ncbi.nlm.nih.gov/pubmed/33371123
http://dx.doi.org/10.1097/MD.0000000000023725
_version_ 1783625073060478976
author Moon, Jee Youn
Lee, Chang-Soon
Yoo, Yongjae
Lee, Suji
Lee, Sang Hoon
Lee, Seunghoon
author_facet Moon, Jee Youn
Lee, Chang-Soon
Yoo, Yongjae
Lee, Suji
Lee, Sang Hoon
Lee, Seunghoon
author_sort Moon, Jee Youn
collection PubMed
description BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when compared with conventional medicine alone. METHODS/DESIGN: This study is a prospective, open-labeled, randomized, cross-over clinical trial. A total of 40 patients with neuropathic pain who had a numeric rating scale (NRS) score of over 4 despite receiving conventional treatment for more than 3 months will be enrolled. Participants will receive conventional treatment for neuropathic pain (treatment C) or treatment C combined with 12 additional sessions of electroacupuncture treatment (treatment A) for 6 weeks. Participants will be randomly assigned to 1 of the 2 sequence groups (AC and CA group) with a 1:1 allocation. The differences of responder in the composite efficacy outcomes, which consist of the NRS, Brief Pain Inventory-Short Form (BPI-SF) pain subscale, and global assessment at 6 weeks after randomization will be examined as the primary outcome. Secondary outcomes include differences in the NRS, the Short-Form McGill Pain Questionnaire, BPI-SF, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Medical Outcomes Study Sleep Scale, global assessment, EQ-5D, and incremental cost-effective ratio at 6 and 15 weeks after randomization. Adverse events, vital signs, and physical examinations will be recorded to evaluate safety. DISCUSSION: The study protocol for this trial will provide up-to-date evidence on the effectiveness and safety of electroacupuncture for patients with intractable neuropathic pain. The results will be disseminated through a peer-reviewed journal and conference presentations. TRIAL REGISTRATION: Clinical Research Information Service, ID: KCT0003615. Registered on March 12, 2019. https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=13410& ltype=&rtype=
format Online
Article
Text
id pubmed-7748203
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77482032020-12-21 Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial Moon, Jee Youn Lee, Chang-Soon Yoo, Yongjae Lee, Suji Lee, Sang Hoon Lee, Seunghoon Medicine (Baltimore) 3800 BACKGROUND: There is no sufficient evidence on the effectiveness of acupuncture for neuropathic pain. This protocol describes a study that aims to evaluate the effectiveness and safety of electroacupuncture combined with conventional medicine for patients with intractable neuropathic pain, when compared with conventional medicine alone. METHODS/DESIGN: This study is a prospective, open-labeled, randomized, cross-over clinical trial. A total of 40 patients with neuropathic pain who had a numeric rating scale (NRS) score of over 4 despite receiving conventional treatment for more than 3 months will be enrolled. Participants will receive conventional treatment for neuropathic pain (treatment C) or treatment C combined with 12 additional sessions of electroacupuncture treatment (treatment A) for 6 weeks. Participants will be randomly assigned to 1 of the 2 sequence groups (AC and CA group) with a 1:1 allocation. The differences of responder in the composite efficacy outcomes, which consist of the NRS, Brief Pain Inventory-Short Form (BPI-SF) pain subscale, and global assessment at 6 weeks after randomization will be examined as the primary outcome. Secondary outcomes include differences in the NRS, the Short-Form McGill Pain Questionnaire, BPI-SF, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Medical Outcomes Study Sleep Scale, global assessment, EQ-5D, and incremental cost-effective ratio at 6 and 15 weeks after randomization. Adverse events, vital signs, and physical examinations will be recorded to evaluate safety. DISCUSSION: The study protocol for this trial will provide up-to-date evidence on the effectiveness and safety of electroacupuncture for patients with intractable neuropathic pain. The results will be disseminated through a peer-reviewed journal and conference presentations. TRIAL REGISTRATION: Clinical Research Information Service, ID: KCT0003615. Registered on March 12, 2019. https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=13410& ltype=&rtype= Lippincott Williams & Wilkins 2020-12-18 /pmc/articles/PMC7748203/ /pubmed/33371123 http://dx.doi.org/10.1097/MD.0000000000023725 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Moon, Jee Youn
Lee, Chang-Soon
Yoo, Yongjae
Lee, Suji
Lee, Sang Hoon
Lee, Seunghoon
Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title_full Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title_fullStr Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title_full_unstemmed Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title_short Evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: A prospective, open-labeled, randomized, cross-over clinical trial
title_sort evaluation of an effectiveness and safety of the electroacupuncture in the management of intractable neuropathic pain: a prospective, open-labeled, randomized, cross-over clinical trial
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748203/
https://www.ncbi.nlm.nih.gov/pubmed/33371123
http://dx.doi.org/10.1097/MD.0000000000023725
work_keys_str_mv AT moonjeeyoun evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial
AT leechangsoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial
AT yooyongjae evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial
AT leesuji evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial
AT leesanghoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial
AT leeseunghoon evaluationofaneffectivenessandsafetyoftheelectroacupunctureinthemanagementofintractableneuropathicpainaprospectiveopenlabeledrandomizedcrossoverclinicaltrial